The FDA has concluded its investigation into an outbreak of salmonella infections associated with Rosabella brand moringa powder capsules distributed by Ambrosia Brands LLC.
As of April 1, 10 cases in eight states have been confirmed in the Salmonella Newport and Kentucky Salmonella outbreaks. Three of the patients required hospitalization. Outbreak strains are highly resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections.
Illness began between September 26, 2025 and January 8, 2026. Seven out of eight people interviewed reported taking Rosabella brand moringa powder capsules. According to the Centers for Disease Control and Prevention (CDC), there are likely more cases linked to this outbreak because for every confirmed case of salmonella, 29 others go undetected.
As part of the outbreak investigation, the Indiana State Department of Health collected unopened product samples from the homes of sick people. The sample tested positive for Salmonella Newport; Whole genome sequencing Analysis showed that this is the same strain of Salmonella Newport that causes illness in this outbreak.
In response to the investigation, Ambrosia Brands, LLC recalled certain Rosabella brand Moringa powder capsules on February 13, 2026. The recalled products were available for sale nationwide and internationally. Products that tested positive for salmonella were also included in the recall. This product should no longer be on the market, but it has a long shelf life. Retailers and consumers should check for recalled products and discard them if found.
Here is a list of lots recalled in connection with the outbreak: Click here.
